Analyst firms · Oppenheimer · TDOC

Oppenheimer TDOC price target and rating history

Teladoc Health Inc. (TDOC) · Health Care

Oppenheimer rates Teladoc Health Inc. (TDOC) Outperform with a $130 price target, as of its latest action on Feb 23, 2022. It has published 4 rating actions on TDOC since July 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50.

Current rating
Outperform
Price target
$130
Median target, all firms
$8.50
Actions on TDOC
4

Oppenheimer price target on TDOC

$220$175$13020222023202420252026
Oppenheimer price target on TDOC, each point a stated target, July 2021 to February 2022.

Every Oppenheimer rating on TDOC

How other firms rate TDOC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchSellNov 2, 2026
Deutsche BankBuy$11Mar 10, 2026
BofA SecuritiesBuy$7Feb 26, 2026
BarclaysEqual Weight$8.50Dec 9, 2025

Questions about Oppenheimer and TDOC

What is Oppenheimer's price target for TDOC?
Oppenheimer's latest stated price target for Teladoc Health Inc. (TDOC) is $130, from its action on Feb 23, 2022.
What is Oppenheimer's rating on TDOC?
Oppenheimer rates TDOC Outperform, a bullish rating, as of Feb 23, 2022.
When did Oppenheimer last change its view on TDOC?
On Feb 23, 2022, Oppenheimer cuts its price target to $130 from $160, keeps Outperform.
How does Oppenheimer's TDOC target compare with other analysts?
Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50.

More TDOC rating histories

All Oppenheimer ratingsTDOC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.